Career Enhancement Program
职业提升计划
基本信息
- 批准号:10415942
- 负责人:
- 金额:$ 9.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-16 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Career Enhancement Program: Project Summary/Abstract
The goal of the Career Enhancement Program (CEP) is to use the translational research resources at the
MD Anderson Cancer Center (MDACC) to solicit and award faculty-level investigators interested in intensive
career development in the field of melanoma research to improve melanoma early detection, prevention,
and treatment. Experienced mentors serve to assist CEP awardees to develop their careers as melanoma
experts, with the goal to reduce the morbidity and mortality from this disease. The CEP will support up to
three one-year awards of $50,000 annually, with a second-year renewal based on acceptable progress.
Funds for the CEP include an annual $50,000 from the SPORE throughout the duration of the overall award,
as well as up to $100,000 per year in institutional “matching funds” from MDACC. Candidates will include the
most promising faculty-level investigators from our institution as well as from the entire Texas Medical
Center, and other SPOREs, with which we interact. The selection of CEP awardees will be based on the
scientific uniqueness, quality, and novelty of the research proposal and the appropriateness of the mentoring
plan, which will be evaluated and scored by our Internal and External Advisory Boards (IAB; EAB). The
awardees will meet with their designated mentors regularly and with CEP leadership at least monthly, and
are expected to participate in and report their progress at monthly SPORE investigator meetings and annual
IAB/EAB meetings. The CEP is led by Dr. Elizabeth Grimm for mentees with laboratory-based projects and
Dr. Jeffrey E. Lee for mentees with clinical projects; both will be involved to mentor translational researchers.
职业提升计划:项目概要/摘要
职业提升计划(CEP)的目标是利用翻译研究资源,
MD安德森癌症中心(MDACC)征求和奖励感兴趣的学院级研究人员密集
在黑色素瘤研究领域的职业发展,以提高黑色素瘤的早期发现,预防,
和治疗。经验丰富的导师服务,以协助CEP获奖者发展他们的职业生涯作为黑色素瘤
专家,目标是减少这种疾病的发病率和死亡率。CEP将支持多达
三项为期一年的奖励,每年50,000美元,第二年根据可接受的进展续签。
CEP的资金包括在整个奖励期间每年从SPORE获得的5万美元,
以及MDACC每年高达10万美元的机构“匹配基金”。候选人将包括
来自我们机构以及整个德克萨斯州医学中心最有前途的学院级研究人员
中心,和其他孢子,与我们互动。选择CEP获奖者将基于
科学的独特性,质量和研究提案的新奇性以及指导的适当性
我们的内部和外部咨询委员会(IAB; EAB)将对该计划进行评估和评分。的
获奖者将定期与他们指定的导师会面,并至少每月与CEP领导会面,
预计将参加并报告他们的进展,在每月的SPORE调查会议和年度
IAB/EAB会议。CEP由Elizabeth Grimm博士领导,为具有实验室项目的学员提供指导,
博士杰弗里·E. Lee为临床项目的学员提供指导;两人都将参与指导转化研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer A. Wargo其他文献
The bacterial microbiome modulates the initiation of brain metastasis by impacting the gut-to-brain axis
细菌微生物组通过影响肠道-大脑轴来调节脑转移的起始。
- DOI:
10.1016/j.isci.2025.111874 - 发表时间:
2025-02-21 - 期刊:
- 影响因子:4.100
- 作者:
Matteo Massara;Michelle Ballabio;Bastien Dolfi;Golnaz Morad;Vladimir Wischnewski;Eleni Lamprou;Joao Lourenco;Stéphanie Claudinot;Hector Gallart-Ayala;Rui Santalla Méndez;Annamaria Kauzlaric;Nadine Fournier;Ashish V. Damania;Matthew C. Wong;Julijana Ivanisevic;Nadim J. Ajami;Jennifer A. Wargo;Johanna A. Joyce - 通讯作者:
Johanna A. Joyce
MAdCAM-1: a newly identified microbial 'gut check' for T cells
MAdCAM-1:一种新发现的针对 T 细胞的微生物“肠道检查”
- DOI:
10.1016/j.it.2023.06.007 - 发表时间:
2023-08-01 - 期刊:
- 影响因子:13.900
- 作者:
Manoj Chelvanambi;Jennifer A. Wargo - 通讯作者:
Jennifer A. Wargo
Case 21-2013
案例21-2013
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:0
- 作者:
Ryan J. Sullivan;Donald P. Lawrence;Jennifer A. Wargo;Kevin S. Oh;R. Gonzalez;A. Piris - 通讯作者:
A. Piris
Gut microbes as biomarkers of ICI response — sharpening the focus
肠道微生物作为免疫检查点抑制剂反应的生物标志物——聚焦
- DOI:
10.1038/s41571-022-00634-0 - 发表时间:
2022-04-21 - 期刊:
- 影响因子:82.200
- 作者:
Neal Bhutiani;Jennifer A. Wargo - 通讯作者:
Jennifer A. Wargo
Errant central line placement
- DOI:
10.1016/j.jclinane.2007.06.003 - 发表时间:
2007-09-01 - 期刊:
- 影响因子:
- 作者:
Robert A. Peterfreund;Jennifer A. Wargo - 通讯作者:
Jennifer A. Wargo
Jennifer A. Wargo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer A. Wargo', 18)}}的其他基金
Project 2 Intrathecal Anti-PD-1 Immunotherapy for Metastatic Melanoma Patients with Leptomeningeal Disease (LMD)
项目2 鞘内注射抗PD-1免疫疗法治疗患有软脑膜疾病(LMD)的转移性黑色素瘤患者
- 批准号:
9978777 - 财政年份:2020
- 资助金额:
$ 9.58万 - 项目类别:
Project 2 Intrathecal Anti-PD-1 Immunotherapy for Metastatic Melanoma Patients with Leptomeningeal Disease (LMD)
项目2 鞘内注射抗PD-1免疫疗法治疗患有软脑膜疾病(LMD)的转移性黑色素瘤患者
- 批准号:
10208809 - 财政年份:2020
- 资助金额:
$ 9.58万 - 项目类别:
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome
(PQ10) 通过调节微生物组增强黑色素瘤中免疫检查点阻断的反应
- 批准号:
9789214 - 财政年份:2018
- 资助金额:
$ 9.58万 - 项目类别:
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome
(PQ10) 通过调节微生物组增强黑色素瘤中免疫检查点阻断的反应
- 批准号:
10245169 - 财政年份:2018
- 资助金额:
$ 9.58万 - 项目类别:
Exploring synergy of combined BRAF-targeted therapy & immunotherapy for melanoma
探索联合 BRAF 靶向治疗的协同作用
- 批准号:
8522168 - 财政年份:2012
- 资助金额:
$ 9.58万 - 项目类别:
Exploring synergy of combined BRAF-targeted therapy & immunotherapy for melanoma
探索联合 BRAF 靶向治疗的协同作用
- 批准号:
9121489 - 财政年份:2012
- 资助金额:
$ 9.58万 - 项目类别:
Exploring synergy of combined BRAF-targeted therapy & immunotherapy for melanoma
探索联合 BRAF 靶向治疗的协同作用
- 批准号:
8383369 - 财政年份:2012
- 资助金额:
$ 9.58万 - 项目类别:
Exploring synergy of combined BRAF-targeted therapy & immunotherapy for melanoma
探索联合 BRAF 靶向治疗的协同作用
- 批准号:
8926888 - 财政年份:2012
- 资助金额:
$ 9.58万 - 项目类别:
Exploring synergy of combined BRAF-targeted therapy & immunotherapy for melanoma
探索联合 BRAF 靶向治疗的协同作用
- 批准号:
8706085 - 财政年份:2012
- 资助金额:
$ 9.58万 - 项目类别:
相似海外基金
HMGB1 in EB-Associated Squamous Cell Carcinoma
EB 相关鳞状细胞癌中的 HMGB1
- 批准号:
10676346 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别:
Examining the impact of laboratory housing temperature on murine CD28 and the response to anti-PD-1
检查实验室外壳温度对小鼠 CD28 的影响以及抗 PD-1 的反应
- 批准号:
10751424 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别:
Advanced machine learning to empower ultra-sensitive liquid biopsy in melanoma and non-small cell lung cancer
先进的机器学习使黑色素瘤和非小细胞肺癌的超灵敏液体活检成为可能
- 批准号:
10591304 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别:
Harnessing the repetitive genome for cancer immunotherapy
利用重复基因组进行癌症免疫治疗
- 批准号:
10664127 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别:
DNA repair dysfunction in cancer induced by altered BRCA2 localization
BRCA2 定位改变引起的癌症 DNA 修复功能障碍
- 批准号:
10739521 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别:
lmmunomodulatory roles of renal lymphatic endothelial cells in Acute Kidney Injury
肾淋巴内皮细胞在急性肾损伤中的免疫调节作用
- 批准号:
10612171 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别:
Harnessing hotspot specific differences among SF3B1 mutations to define novel mechanisms of tumorigenicity and targetability in solid malignancies
利用 SF3B1 突变之间的热点特异性差异来定义实体恶性肿瘤的致瘤性和靶向性的新机制
- 批准号:
10747548 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别:
Investigating the role of GAPDHS in melanoma metabolism and metastasis
研究 GAPDHS 在黑色素瘤代谢和转移中的作用
- 批准号:
10643669 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别:
Investigating CD4+ T cell memory in cancer immunotherapy
研究癌症免疫治疗中的 CD4 T 细胞记忆
- 批准号:
10739583 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别:
The role of the novel interface cell state in melanoma invasion
新型界面细胞状态在黑色素瘤侵袭中的作用
- 批准号:
10591187 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别:














{{item.name}}会员




